News & Events

Umoja Biopharma Appoints Renowned Oncologist and Industry Leader Dr. Nushmia Khokhar as Chief Medical Officer
April 6, 2021

Seattle, Wash., April 6, 2021– Umoja Biopharma, a biotechnology company pioneering an integrated, in vivo immunotherapy platform, today announced the appointment of Nushmia Khokhar, M.D., as Chief Medical Officer. “We are excited to welcome Dr. Khokhar to the Umoja team.…

READ MORE >

Umoja Biopharma Appoints Dr. Robert Glassman to its Board of Directors
March 12, 2021

Seattle, Wash., January 25, 2021 – Umoja Biopharma, a biotechnology company pioneering an integrated, in vivo immunotherapy platform, today announced the appointment of Rob Glassman, M.D., to its Board of Directors. “We are pleased to welcome Dr. Glassman to Umoja’s…

READ MORE >

Umoja Biopharma Launches with $53M Series A Financing to Develop Fully Integrated, Scalable, In Vivo Immunotherapy Platform
March 12, 2021

Umoja’s platform addresses key limitations of existing engineered immunotherapies. Company backed by prominent life science investors MPM Capital, DCVC Bio and Qiming Venture Partners USA and led by an experienced team of scientist/entrepreneurs. Seattle, Wash., November 18, 2020 – Umoja…

READ MORE >

We are led by a world class team that operates on a foundation of respect for the contributions of everyone on the Umoja team.